Physician profile
Carla H Terrell
NPI 1053954073
$2,031.22
in general payments reported to CMS, 2019-2025
24 companies · $1,789 in 2025
The $1,789 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5.45 · 2022: $24.04 · 2024: $212 · 2025: $1,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,917 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,916.74 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $336.33 | 2024-2025 | Erleada, Carvykti, Rybrevant |
| Pfizer INC. | $207.87 | 2024-2025 | |
| 180 Medical, INC. | $165.31 | 2024-2025 | |
| Endo USA, INC. | $159.31 | 2024-2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $158.82 | 2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $153.93 | 2024-2025 | |
| Abbvie INC. | $107.76 | 2025 | |
| Immunitybio, INC. | $96.81 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $91.45 | 2025 | Bard Urinary Drainage Bag |
| Seagen INC. | $84.99 | 2025 | |
| Boston Scientific Corporation | $58.71 | 2025 | Ams 700, Axonics |
| Progenics Pharmaceuticals, INC. | $58.00 | 2025 | |
| Teleflex LLC | $48.85 | 2024-2025 | Urolift, Barrigel |
| Ferring Pharmaceuticals INC. | $44.02 | 2025 | Adstiladrin |
| Procept Biorobotics Corporation | $41.81 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $35.71 | 2025 | |
| Tolmar, INC. | $34.82 | 2025 | Jatenzo, Eligard |
| Calyxo, INC. | $29.07 | 2024 | Cvac Aspiration System |
| Blue Earth Diagnostics | $26.19 | 2025 | Posluma |
| Gilead Sciences, INC. | $24.04 | 2022 | |
| Olympus America INC. | $22.68 | 2025 | Itind System |
| Adc Therapeutics America, INC. | $20.74 | 2025 | |
| Axonics, INC. | $18.55 | 2024 | Axonics |
| Genentech USA, INC. | $5.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.